Biofrontera Inc. 8-K

What Happened

• On May 14, 2026, Biofrontera Inc. announced its financial and operational results for the three months ended March 31, 2026 via a press release furnished as Exhibit 99.1 to a Form 8‑K (Item 2.02). The press release contains the company’s reported quarterly results and discussion of operations.

Key Details

• Press release dated May 14, 2026 was furnished as Exhibit 99.1 to the Form 8‑K.
• Results cover the quarter ended March 31, 2026 (first quarter of 2026).
• The press release includes non‑GAAP financial measures and provides quantitative reconciliations to the most directly comparable GAAP measures in accordance with Regulation G.

Why It Matters

• This filing provides the company’s latest quarterly earnings/operational update; retail investors should review the press release to see revenue, profit/loss, cash flow and management commentary.
• The inclusion of non‑GAAP measures plus reconciliations lets investors compare management’s adjusted metrics to GAAP figures; check both sets of numbers when evaluating performance.
• After reviewing the press release, investors may also want to watch for the company’s formal periodic filings (e.g., 10‑Q) for additional details and audited or more complete financial disclosures.